FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

AngioDynamics Says Many Steps Respond to FDA Inspections

[ Price : $8.95]

AngioDynamics reports in an SEC filing steps it has taken many steps to respond to multiple FDA inspections at two of its faciliti...

Course on Small Clinical Trials

[ Price : $8.95]

Federal Register Notice: FDA and the National Institutes of Health Office of Rare Diseases Research will hold a course 11/27-28, T...

FDA Clears Alma Laser Skin Resurfacing Module

[ Price : $8.95]

FDA clears an Alma Lasers 510(k) for its PixelRF fractionated skin resurfacing module for cosmetic use with its Accent laser produ...

Mobile Medical App Policy Being Finalized

[ Price : $8.95]

CDRH official says the Center intends to finalize its draft guidance on mobile medical applications by the end of the year.

Info on Rx Drug Promotion Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection of information on a survey of prescription drug promotion to the Office...

Panel to Discuss CoAxia NeuroFlo Catheter Device

[ Price : $8.95]

Federal Register Notice: FDAs Neurological Devices Panel will meet 11/1 the safety and effectiveness of the CoAxia NeuroFlo Cathet...

FDA Risk Panel Takes Up Warning Fatigue

[ Price : $8.95]

FDAs Risk Communication Advisory Committee schedules an 11/2 panel meeting to discuss how to avoid message or warning fatigue with...

FDA Says Some Opana ER Abusers Suffer Thrombocytopenia

[ Price : $8.95]

FDA says it has learned about some Opana ER abusers who are suffering from thrombotic thrombocytopenic purpura that has caused one...

Did Dendreon Hide Provenge Problems?

[ Price : $8.95]

Reuters says Dendreon may have changed its statistical analysis of a key Provenge trial to produce a more favorable efficacy resul...

New Research Shows How Cancer Cells Spread

[ Price : $8.95]

New research sheds more light on how metastatic cancer cells spread from primary tumors to the lungs and bones.